Filter by content type
Filter by year
Vaccinex Reports Third Quarter 2018 Financial Results and Provides Corporate Update
November 13, 2018 - … trials in cancer and Huntington’s Disease Enrollment in CLASSICAL Lung Cancer trial and Cohort B of the SIGNAL Huntington’s … Non-Small Cell Lung Cancer (NSCLC). In the company’s CLASSICAL study, which is evaluating pepinemab in combination …
Vaccinex, Inc. to Present at the Ladenburg Thalmann 2018 Healthcare Conference
September 25, 2018 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based …
Vaccinex, Inc. Gives Podium Presentation and Poster at the Society for Immunotherapy of Cancer Annual Meeting
November 15, 2018 - … trial in combination with avelumab for non-small cell lung cancer, a Phase 1 study in combination with nivolumab or … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … trial in combination with avelumab for non-small cell lung cancer, a Phase 1 study in combination with nivolumab or …
Vaccinex, Inc. to Participate on a Panel and Meet with Investors at the BTIG Healthcare Conference October 25, 2018
October 23, 2018 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based …
Vaccinex, Inc. to Participate in Podium and Poster Sessions at the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
September 27, 2018 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based …
Vaccinex, Inc. to Present Data on Its Semaphorin 4D Monoclonal Antibody Programs at Two Conferences Focused on Cancer Immunotherapy and Huntington’s Disease
November 6, 2018 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based …
Vaccinex Announces Pricing of Initial Public Offering
August 9, 2018 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in …
Preclinical Data on Vaccinex, Inc. Anti-SEMA4D Monoclonal Antibody in Combination with Checkpoint Inhibitors Published in Cancer Immunology Research
December 12, 2018 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based …
Vaccinex, Inc. Presents Overview of the Clinical Development of VX15 (pepinemab) for the Potential Treatment of Huntington’s Disease at the Huntington Study Group’s 2018 Annual Meeting
November 12, 2018 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based …
Vaccinex, Inc. Presents Preliminary Data on Its Anti-Semaphorin 4D Monocolonal Antibody Technology at the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
October 2, 2018 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based …
Pagination
- Page 1
- Next page